Cargando…
Precise CCM1 gene correction and inactivation in patient‐derived endothelial cells: Modeling Knudson's two‐hit hypothesis in vitro
BACKGROUND: The CRISPR/Cas9 system has opened new perspectives to study the molecular basis of cerebral cavernous malformations (CCMs) in personalized disease models. However, precise genome editing in endothelial and other hard‐to‐transfect cells remains challenging. METHODS: In a proof‐of‐principl...
Autores principales: | Spiegler, Stefanie, Rath, Matthias, Much, Christiane D., Sendtner, Barbara S., Felbor, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625102/ https://www.ncbi.nlm.nih.gov/pubmed/31124307 http://dx.doi.org/10.1002/mgg3.755 |
Ejemplares similares
-
Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening
por: Schwefel, Konrad, et al.
Publicado: (2018) -
Inactivation of Cerebral Cavernous Malformation Genes Results in Accumulation of von Willebrand Factor and Redistribution of Weibel-Palade Bodies in Endothelial Cells
por: Much, Christiane D., et al.
Publicado: (2021) -
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
por: Pagenstecher, Axel, et al.
Publicado: (2009) -
Cas9-Mediated Nanopore Sequencing Enables Precise Characterization of Structural Variants in CCM Genes
por: Skowronek, Dariush, et al.
Publicado: (2022) -
Novel Pathogenic Variants in a Cassette Exon of CCM2 in Patients With Cerebral Cavernous Malformations
por: Much, Christiane D., et al.
Publicado: (2019)